{
    "2019-05-23": [
        [
            {
                "time": "2018-03-01",
                "original_text": "公司获QFII连续三季度加仓，偏爱两领域，普遍越跌越买",
                "features": {
                    "keywords": [
                        "QFII",
                        "加仓",
                        "越跌越买"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-15",
                "original_text": "北上资金5月“变天”：连续6日净流出，偏好低价股",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净流出",
                        "低价股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "医药生物行业18年报及19年一季报回顾:医药整体业绩探底,内部分化明显",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩探底",
                        "分化"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-10",
                "original_text": "医药生物行业2019q1业绩前瞻-2019q1医药板块整体增长稳健,个股业绩持续分化",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩增长",
                        "稳健"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "【国信医药】中国生物制药（1177.HK）：研发捷报频传，持续成长可期",
                "features": {
                    "keywords": [
                        "中国生物制药",
                        "研发",
                        "成长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-01",
                "original_text": "炸了！年销售费80亿，每天举办169场活动，这家公司还能吹多久？",
                "features": {
                    "keywords": [
                        "销售费",
                        "活动",
                        "质疑"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-05",
                "original_text": "国金证券：从2018年上市公司年报看国内医药研发(附股)",
                "features": {
                    "keywords": [
                        "医药研发",
                        "年报",
                        "国金证券"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-05",
                "original_text": "【国金晨讯精选】就业压力专题研究（固收），中国医药研发专题研究",
                "features": {
                    "keywords": [
                        "医药研发",
                        "专题研究",
                        "国金晨讯"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-25",
                "original_text": "5月以来两融余额下降270亿 杠杆资金逆势加仓150只潜力股",
                "features": {
                    "keywords": [
                        "两融余额",
                        "杠杆资金",
                        "加仓"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-10",
                "original_text": "中国医药行业研发专题分析报告:转型、创新、发展,中国医药研发蓬勃兴起,从2018年上市公司年报看国内医药研发",
                "features": {
                    "keywords": [
                        "医药研发",
                        "转型",
                        "创新"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}